Pluribus Labs’s Bruker BRKR Stock Holding History

Pluribus Labs’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,667	Closed	-$392K	–	78
2021 Q4	$392K	Buy	+4,667	New	+$374K	0.41%	84

Other funds holding BRKR

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return

Pluribus Labs's BRKR Position: Q1 2022 in Review

Pluribus Labs sold out of Bruker (BRKR) in Q1 2022, closing a stake of 4,667 shares — an estimated $392K sold.

Pluribus Labs first reported a position in BRKR in Q4 2021 and held it in 1 quarter. The position peaked at $392K in Q4 2021. 311 funds tracked by Wall St. Rank hold BRKR as of Q1 2022.

Pluribus Labs reported no remaining Bruker position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 4,667 Bruker shares in Q1 2022, an estimated $392K.
Pluribus Labs first reported a position in Bruker in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Bruker position peaked at $392K in Q4 2021.
311 funds tracked by Wall St. Rank held Bruker as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.